Canada Transcatheter Heart Valves Market Report and Forecast 2026-2034

Study Period

2020-2034

Market (2025)

USD 4.17 Billion

Market (2034)

USD 11.80 Billion

CAGR

12.25%

Major Markets Players

Transcatheter Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Laboratories, JenaValve Technology, Inc. and Others

Canada Transcatheter Heart Valves Market Overview: Market Size & Forecast (2026–2034)

What is the anticipated CAGR & size of the Canada Transcatheter Heart Valves Market?

The Canada Transcatheter Heart Valves Market is anticipated to register a CAGR of around 12.25% during the forecast period, 2026-34. Additionally, the market size was valued at nearly USD 4.17 billion in 2025 and is projected to reach almost USD 11.80 billion by 2034.

Market Analysis & Insights

The Canada Transcatheter Heart Valves Market growth is encouraged by expanding geriatric population, surging prevalence of valvular heart disease (VHD), and the booming market demand for minimally invasive cardiac procedures. Also, leading market companies, such as Edwards Lifesciences (SAPIEN), Medtronic (CoreValve), Abbott (MitraClip), and several others, advantage from solid Health Canada approval & expanding procedure volumes across the Canadian healthcare system.

Furthermore, hospitals & ambulatory surgery centers have more lucrative market opportunities than specialist clinics since the high cost of heart valve replacement in Canada is diminished by better patient outcomes & shorter recovery times. Also, innovation is highlighted in the market study, like the development of self-expandable & balloon-expandable valves and the expansion of catheter-based treatments for more complicated situations. Besides, increased TAVR reimbursement & investments in health infrastructure are instances of government actions that facilitate Canada Transcatheter Heart Valves Market progression. Further, clinical trial results, rivalry for procedural volumes, and changes in regulations all have an impact on large corporations across Canada.

Additionally, as the Canada Transcatheter Heart Valves Market adopts new technology, distribution networks, and expanding hospital vs ASC segmentation. Also, the future of minimally invasive cardiac surgery in Canada is being advanced by recent collaborations, launches, and clinical trials that display rising momentum in the volume of TAVI & TMVR procedures in Canada in the future years.

What is the Impact of AI in the Canada Transcatheter Heart Valves Market?

The adoption of artificial intelligence (AI) is having a tremendous impact on the Canadia Transcatheter Heart Valves Market by utilizing improved cardiac imaging & clinical trial analytics to optimize patient selection & procedural planning. For instance, Abbott deployed machine learning techniques to find candidates for MitraClip & TMVR, enhancing procedural success & post-operative outcomes at Canadian cardiac clinics, while Medtronic experimented with AI-driven valve assessment software.

Canada Transcatheter Heart Valves Market Dynamics

What driving factor acts as a positive influencer for the Canada Transcatheter Heart Valves Market?

• High Procedure Volume Instigated by Aging Demographics: The increasing number of elderly Canadians is a prominent market driver, instigated an unprecedented demand for minimally invasive cardiac operations for valvular heart disease (VHD), mitral regurgitation, and aortic stenosis. Further, with a market share of more than 60% as of 2024, high-risk patients are progressively opting TAVR operations, which take advantage of Canada's sophisticated healthcare system & robust Health Canada approval for platforms such as Medtronic CoreValve & Edwards SAPIEN.

What are the challenges that affect the Canada Transcatheter Heart Valves Market?

• Cost & Reimbursement Uncertainty Limits Market Uptake: A substantial industry challenge is the high heart valve replacement expenses, which generally varies between hospital & ASC market segments. Moreover, restrictions in public reimbursement for transcatheter heart valve replacement procedures, together with the cost of devices & necessary post-operative care, limit access & delay prevalent adoption despite clinical trial data Canada supports wider indications.

How are the future opportunities transforming the market during 2026-34?

• Untapped Opportunity in Low-Risk Patient Growth: Evolving catheter-based valve therapy applications for low-risk patients present an innovative potential. As new-generation balloon-expandable valves have better results than self-expandable valves, clinical guidelines are progressively supporting minimally invasive treatments for less severe situations. Also, as TAVI operation volume continues to surge, the Canadian Transcatheter Heart Valves Market is foreseen to expand, escalating the scope of hospital & enhancing reimbursement systems.

What market trends are affecting the Canada Transcatheter Heart Valves Market Outlook?

• Transistion from Transapical to Transfemoral Approach: A prominent trend is the shift from transapical to transfemoral approaches across the Canada’s THV Market, with transfemoral surpassing about 58% market share by 2034. Further, this is accredited to procedural simplicity, reduced complication rates, and higher patient satisfaction, paving the way for the future of minimally invasive heart surgery across the country.

How is the Canada Transcatheter Heart Valves Market Defined as per Segments?

The Canada Transcatheter Heart Valves Market Research Reports provide detailed market data & insights in accordance with market segmentation. Some of the segments are:

• Valve Type: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve, Replacement (TMVR), Transcatheter Pulmonary Valve Replacement
• Product: Balloon-Expandable Valves, Self-Expandable Valves, Mechanically Expanded Valves, Transcatheter Mitral Valve Repair & Replacement

By Valve Type:

The Transcatheter Aortic Valve Replacement (TAVR) segment comprises a market share of over 70% in 2025.

The great prevalence of aortic stenosis & quick adoption in Canadian institutions, which reflects good clinical outcomes & a high volume of TAVI procedures performed in Canada, are the key drivers encouraging the usage of TAVR valve type.

By Product:

The Balloon-expandable Valves, notably also known as the Edwards SAPIEN, captures the potential share of about 52% in 2025 of the Canada Transcatheter Heart Valves Market.

The segment is primarily preferred over self-expandable alternatives in catheter-based valve therapy in Canada owing to their dependable deployment, excellent clinical track record, and extensive knowledge among cardiac surgeons for both hospital & ASC industry sectors.

Canada Transcatheter Heart Valves Market: What Recent Innovations Are Affecting the Industry?

• 2025: Edwards Lifesciences introduced a next-generation balloon-expandable transcatheter heart valve platform including proprietary calcification-resistant tissue technology, minimizing valve deterioration & reintervention while enabling advanced valve-in-valve procedures for aortic stenosis & valvular heart disease (VHD) patients.
• 2025: Medtronic launched the Evolut™ FX+ system, precisely intended to facilitate easier coronary access & enhance procedural performance for patients undergoing severe aortic stenosis interventions, building on the CoreValve™ technology & supporting future coronary procedures in minimally invasive cardiac settings.

What are the Key Highlights of the Canada Transcatheter Heart Valves Market (2026–34)?

How does the Future Outlook of the Canada Transcatheter Heart Valves Market (2034) Appear?

• Sustained Growth: Constant upsurge in aortic stenosis occurrence, intriguing Health Canada approval processes, and expanding hospital vs ASC market segment access would sustain the Canada Transcatheter Heart Valves Market size of nearly 12.25% CAGR during 2026-34 & projected value of about USD 11.80 billion by 2034.
• Technological Upgrade: The projected market years would be shaped by the proliferation of long-lasting, minimally invasive valves, mainly balloon-expandable versus self-expandable valves, as well as clinical advancements in transcatheter mitral valve repair (TMVR) & transcatheter tricuspid valve repair in Canada.
• Future Opportunities: The high market demand would be influenced by ongoing investments, clinical trial data, and strong partnerships. Also, in the future years AI is foreseen to enhance post-operative care, risk assessment, and patient selection.

Top Companies in Canada Transcatheter Heart Valves Market

What Does Our Canada Transcatheter Heart Valves Market Research Study Entail?

• The Canada Transcatheter Heart Valves Market Research Report highlights the forecast growth rate (CAGR) by anticipating the market size and share.
• The market analysis & market scope sheds light upon the primary industry trends, driving aspects, potential opportunities, growth challenges, and other major factors.
• The Canada Transcatheter Heart Valves Market Research Report entails details about the most critical shifts in market share in the prominent regions.
• Considering the statistics & the developments by the primary market competitors, our report also strives to demonstrate the most sought-after strategies of the key players.